Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicine in China. It offers NormalGEN, a type of biological dura repair patch manufactured from animal tissue; GrandNeuro, an artificial dura patch for dura repairing; ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; DermalGEN, a wound dressing product manufactured from animal tissue for use on burns, scalds, and wounds due to skin loss or trauma; and IREAL breast patch. The company was founded in 1999 and is based in Guangzhou, China.

History

Guanhao Biotech was founded in 2002 by a team of professionals who had a shared vision - to use cutting-edge biotechnologies to revolutionize the healthcare industry. To that end, Guanhao Biotech has developed numerous innovative therapeutic solutions and treatments, which have been recognized in the industry.

Mission

To make a positive impact through scientific advancement, by discovering, developing and delivering ground-breaking treatments and cures that improve the lives of people worldwide.

Vision

Guanhao Biotech Company strives to develop the world's best biotechnologies and create treatments that preserve the quality and extend the quantity of life of those we serve.

Key Team

Mr. Bin Xu (CEO, Vice-Director of National Engineering Laboratory & Non-Independent Director)

Prof. Guofeng Xu (Chief Technology Officer)

Mr. Minjie Hu (Chief Scientist of Cell and Stem Cell Research)

Recognition and Awards

Guanhao Biotech has received several awards for its groundbreaking innovations, including the 2018 Asia-Pacific Technology Award for its pioneering work in gene editing.

References

https://in.investing.com/equities/grandhope-biotech

https://finance.yahoo.com/quote/300238.SZ/profile?p=300238.SZ

https://www.crunchbase.com/organization/grandhope-biotech

https://www.guanhaobio.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Leadership team

Mr. Bin Xu (CEO, Vice-Director of National Engineering Laboratory & Non-Independent Director)

Prof. Guofeng Xu (Chief Technology Officer)

Mr. Minjie Hu (Chief Scientist of Cell and Stem Cell Research)

Products/ Services

Biotechnology, Manufacturing

Number of Employees

500 - 1000

Headquarters

Guangzhou, Guangdong, China

Established

1999

Net Income

5M - 20M

Revenue

20M - 100M

Traded as

SZSE:300238

URL

https://www.guanhaobio.com

Last updated: Tue Feb 25 2025

We value your privacy

Guanhao Biotech

Table of content

Summary